Effect of Synthesis Method of La1 − xSr x MnO3 Manganite Nanoparticles on Their Properties
- 220 Downloads
Nanoparticles of lanthanum-strontium manganite were synthesized via different methods, namely, sol-gel method, precipitation from non-aqueous solution, and precipitation from reversal microemulsions. It was shown that the use of organic compounds and non-aqueous media allowed significantly decreasing of the crystallization temperature of nanoparticles, and the single-phased crystalline product was formed in one stage. Morphology and properties of nanoparticles depended on the method and conditions of the synthesis. The heating efficiency directly depended on the change in the magnetic parameters of nanoparticles, especially on the magnetization. Performed studies showed that each of these methods of synthesis can be used to obtain weakly agglomerated manganite nanoparticles; however, particles synthesized via sol-gel method are more promising for use as hyperthermia inducers.
PACS: 61.46.Df 75.75.Cd 81.20. Fw
KeywordsManganite nanoparticles Sol-gel Non-aqueous solution Microemulsion Magnetization Specific loss power
Structure and properties of magnetic materials differ from those of bulk materials in the transition to the nanoscale . In addition to possible practical application in various magnetic sensors, magnetic recording systems , magnetic nanoparticles are of particular interest in the possibilities of practical use in medicine. Researchers study many possible medical directions of their application: delivery of drugs and biological objects [3, 4], biomarkers , magnetic resonance imaging (MRI) [6, 7], etc.
One of the promising directions for medical application of magnetic nanoparticles is hyperthermia—locally heating the oncological tumors under the action of an alternating magnetic field to 43–45 °C, at which the tumor cells die . Application of an external alternating magnetic field is accompanied by a number of problems: uneven and uncontrolled heating tumor, risk of overheating and destruction of healthy tissues, and impossibility of heating the deep-seated tumors. Therefore, in 1993, Prof. Jordan suggested the idea of magnetic hyperthermia, which consisted in the use of the magnetic nanoparticles and an alternating magnetic field . In this case, the magnetic nanoparticles must be previously injected into the tumor, and such tumor must be affected by an alternating magnetic field. Particle temperature will increase by the absorption of magnetic energy and provide the local heating. However, such nanoparticles must satisfy a number of requirements: small sizes and weak agglomeration of nanoparticles; such particles must be single domain and superparamagnetic (to prevent interactions between individual nanoparticles in the absence of magnetic field), and they must effectively heat up in the alternating magnetic field to the required temperatures (43–45 °C) and demonstrate high specific loss power (SLP) values.
At present, magnetic nanoparticles of the magnetite Fe3O4 with a spinel structure are actively investigated as possible mediators of hyperthermia treatment [7, 10, 11]. Magnetite is characterized by a high value of Curie temperature (TC ≈ 580 °C) —the transition temperature from magnetic to paramagnetic state. Since magnetic nanoparticles heat up in an alternating magnetic field only when they are in a magnetic state (up to TC point), in the case of magnetite, the heating is uncontrollable up to high temperatures. It may result in overheating and destroying the healthy tissues.
To prevent this problem, it is important to search for the alternative materials, in which the Curie point will be in the temperature range that is necessary for hyperthermia. In this case, heterosubstituted manganites of lanthanum-strontium La1 − xSr x MnO3 (LSMO) with the distorted perovskite structure are of particular interest. They have the phase transition temperature near 45 °C that provides the controlled heating temperature without any additional thermoregulative devices.
Crystallization energy of materials with the perovskite structure is much higher than that for spinel structure . Due to this reason, an amorphous phase is always formed in the first stage regardless of the method of synthesis of nanoparticles with the perovskite structure from solutions. Preparation of the crystalline product requires additional temperature treatment that leads to the agglomeration of the nanoparticles. Investigations described in  showed that formation of the crystalline structure after precipitation from aqueous solutions and further heating the powder is a multi-stage process; single-phased crystalline product is obtained at temperatures higher than 1100 °C. Such particles have large sizes and form large agglomerates. Therefore, it is relevant to search for alternative methods for synthesis of weakly agglomerated La1 − xSr x MnO3 nanoparticles using non-aqueous media and organic compounds. It is possible to highlight such methods as precipitation from non-aqueous solution, microemulsion synthesis, and sol-gel method. In these cases, the formation of nanoparticles will take place either in the decomposition of previously formed organic-inorganic complexes (precipitation and sol-gel method) or in the isolated volume (microemulsions); the parameters of which can be controlled by the selection of different organic compounds.
Therefore, the aim of this study was the synthesis of nanoparticles of lanthanum-strontium manganite (La1 − xSr x MnO3) via different methods (precipitation from non-aqueous solution, synthesis in microemulsion, and sol-gel method) and investigation of morphology and properties of obtained nanoparticles.
Methods of Synthesis
In sol-gel synthesis of LSMO manganite nanoparticles, the necessary molar amounts of metal salts La(NO3)3, Mn(NO3)2, Sr(NO3)3 were dissolved in bidistilled water. Citric acid (CA) and ethylene glycol (EG) were added to the resulting solution as gel-forming agents in a molar ratio CA/EG = 1:4. The molar ratio of salts to the gel-forming mixture was 1:10. The obtained mixture was heated at 80 °C with stirring. A polymer gel was formed as a result of polyesterification reaction, and it was pyrolyzed at 200 °C. Precursor powder obtained as a result of pyrolysis was subjected to heat treatment at different temperatures for 2 h.
For the precipitation of LSMO manganite nanoparticles from a non-aqueous medium, the concentrated aqueous solutions of metal nitrates, La(NO3)3 (CLa = 1.2 M), Mn(NO3)2 (CMn = 1.5 M), and Sr(NO3)3 (CSr = 1.6 M), were used as starting reagents and sodium hydroxide as the precipitator. Diethylene glycol (DEG) was used as the reaction medium. To obtain 0.01 mol of manganite, a mixture of metal nitrates was added to 1.5 mol of DEG in the three-neck flask in the argon atmosphere and heated up to 200 °C. One hundred milliliters of previously prepared sodium hydroxide solution in DEG (CNaOH = 0.5 M) was added dropwise to the obtained mixture with constant stirring. The resulting reaction system was heated in the oil bath to 200–220 °C with stirring for 1 h and held for 1 h at this temperature. The precursor obtained after the synthesis was mixed with the oleic acid, and this mixture was cooled to room temperature. Obtained nanoparticles were separated by centrifugation, dispersed in ethyl alcohol, and dried in the air at 30–50 °C. To obtain crystalline nanoparticles, the synthesized precursor was heat-treated at different temperatures for 2 h.
To precipitate manganite LSMO nanoparticles from reversal microemulsions, aqueous solutions of La(NO3)3 (CLa = 1.2 M), Mn(NO3)2 (CMn = 1.5 M), and Sr(NO3)3 (CSr = 1.6 M) were used as starting reagents and cetyltrimethylammonium bromide (CTAB) and Triton X-100 as surfactants. n-Butanol was used as the additional surfactant which was not involved in the formation of micelles, and cyclohexane and bidistilled water were used as the solvent and dispersed medium, respectively. Concentrated aqueous ammonia solution was used as the precipitator. At the first stage, two microemulsions (M1 and M2) were prepared. They consisted of the corresponding aqueous phase (solution of salts (M1) or precipitant solution (M2)), surfactant, n-butanol, and cyclohexane. Percentage of microemulsion components in the case of CTAB-based microemulsion are the following: 10.5% of surfactant, 21% of n-butanol, 50.5% of cyclohexane, and 18% of aqueous phase and in the case of Triton X-100-based microemulsion: 15% of surfactant, 20% of n-butanol, 48% of cyclohexane, and 17% of aqueous phase. M2 was added dropwise to M1 with stirring for 1 h at 70 °C. The obtained precipitate was separated by centrifugation and washed several times with isopropanol and bidistilled water. Corresponding amorphous powders were heat-treated at different temperatures for 2 h.
Synthesized nanoparticles were studied by X-ray method using diffractometer DRON-4 (CuKα radiation).
Particle morphology was investigated by transmission electron microscope (TEM) JEOL JEM-1400. Average sizes and particle size distributions were calculated as described in  using Image Tool 3 and OriginPro 8.5 SR1 software packages.
Magnetic measurements were performed using LDJ-9500 vibrating sample magnetometer.
Results and Discussion
Synthesis with using the non-aqueous media and organic compounds has its own features. In sol-gel synthesis, nanoparticles of La-Sr manganite are obtained after pyrolysis of the polyester between citric acid and ethylene glycol, formed during the polyesterification reaction. In the case of precipitation from DEG solution, manganite nanoparticles are obtained during decomposition of corresponding complexes formed between DEG molecules and metal ions. Detailed investigations of the synthesis process are described in . Two microemulsions of oil-in-water type are used in the synthesis of nanoparticles from microemulsions. Each of these microemulsions consists of the surfactant, aqueous solution of salts or precipitator, and organic non-polar solvent. Such microemulsions allow isolating the aqueous solutions in the limited volume by the formation of micelles. Synthesis of material takes place in a limited volume, in so-called nanoreactor.
Obtained results of TEM studies indicate that nanoparticles synthesized via different methods are characterized by a narrow size distribution; their average particle diameter is in the range of 20–40 nm. According to literature data, the average size of single-domain nanoparticles for manganite is about 70 nm . Therefore, synthesized nanoparticles are single-domain ones, which is a necessary requirement for obtaining superparamagnetic properties.
Sizes and magnetic parameters for LSMO nanoparticles synthesized via different methods
Method of synthesis of La1 − xSr x MnO3
Precipitation from DEG solution
Synthesis from microemulsion based on Triton X-100
Synthesis from microemulsion based on CTAB
Average particle size
35 ± 5
25 ± 5
19 ± 5
26 ± 8
Coercive force H, Oe
Magnetization saturation M, emu/g
Blocking temperature (K)
It is important to highlight that the heating temperature becomes stable after some time interval of action of an alternating magnetic field in all cases (Fig. 4). Maximal heating temperature depends especially on the magnetization. This is a very important result because it allows controlling the heating in the required temperature range automatically. Such approach gives a possibility to avoid the overheating and damaging of the healthy tissues in the hyperthermia treatment. However, taking into account the data of magnetic measurements, manganite nanoparticles synthesized via sol-gel method are more suitable for magnetic hyperthermia because they heat up to required temperatures (43–45 °C) in an alternating magnetic field more efficiently.
LSMO manganite nanoparticles were synthesized via three methods: sol-gel, precipitation from DEG solution, and precipitation from microemulsions, where two different surfactants were used. Application of such methods allowed producing the single-phased crystalline nanoparticles in one stage at lower temperatures (up to 800 °C) compared to other methods. It was established the significant effect of method and conditions of synthesis on the morphology and properties of the nanoparticles. Calculated particle sizes are of 20–40 nm, and such particles are single-domain ones. Magnetization of nanoparticles changes in direct proportion to decreasing the particles size that affects the heating efficiency. It was shown that nanoparticles synthesized via sol-gel method better heat up in an alternating magnetic field (SLP = 38 W/g) since they have higher magnetization values. Heating temperature for all nanoparticles goes to saturation after some time that is very important for application of manganites as the hyperthermia inducers. Complex of investigations showed the possibility to synthesize weakly agglomerated, superparamagnetic manganite nanoparticles via the methods described in this paper. However, LSMO nanoparticles synthesized via the sol-gel method are more promising as the inducers in hyperthermia treatment compared with the other ones because they have better magnetic characteristics and higher heating efficiency in an alternating magnetic field (SLP = 38 W/g).
This research was supported by the Target Program of Scientific Researches of the National Academy of Sciences of Ukraine “Materials for medicine and medical technology and technologies for their obtaining and application.” The appreciation for the possibility of electron microscopic studies is expressed to Maxim Harchuk and Center for Shared Use of Danylo Zabolotny Institute of Microbiology and Virology of NAS of Ukraine.
YS synthesized the nanoparticles, designed and performed the X-ray experiments and heating efficiency study, and analyzed the data. SS performed the TEM investigations and took part in analyzing the obtained results. AT performed the investigations of magnetization and analyzed the obtained results. YS, SS, and AT contributed in the drafting and revision of the manuscript. AB supervised the work and finalized the manuscript. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
- 3.McBain SC, Yiu HH, Dobson J (2008) Magnetic nanoparticles for gene and drug delivery. Int J Nanomedicine 3:169–180Google Scholar
- 4.Mody VV., Cox A., Shah S., Singh A., Bevins W., Parihar H. (2014). Magnetic nanoparticle drug delivery systems for targeting tumor. Appl. Nanosci 4:385-392./Google Scholar
- 8.Solopan S, Belous A, Yelenich A, Bubnovskaya L, Kovelskaya A, Podoltsev A, Kondratenko I, Osinsky S (2011) Nanohyperthermia of malignant tumors. I. Lanthanum-strontium manganite magnetic fluid as potential inducer of tumor hyperthermia. Exp Oncol 33:131–135Google Scholar
- 14.Belous AG, Pashkova YV, Vunov OI, Danil'chenko KP, Yanchevskij OZ, Tovstolytkin AI, Khomenko BS, Durilin DA (2005) Effect of processing conditions on the phase transformations, structure and magnetoresistive properties of La0.7Sr0.3MnO3±γ manganites. Ukrainian Chem J 71:17–23Google Scholar
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.